Document is current
Any future updates will be listed below
-
Authors
De Corso, Eugenio https://orcid.org/0000-0001-5761-7018
Montuori, Claudio https://orcid.org/0000-0003-2070-0314
Baroni, Silvia
Mastrapasqua, Rodolfo F.
Porru, Davide P.
D’Auria, Leandro M. https://orcid.org/0009-0007-7101-1080
D’Agostino, Giuseppe https://orcid.org/0000-0002-2518-3435
Penazzi, Daniele
De Maio, Gabriele
Onori, Maria E.
Sarlo, Francesca
Corbo’, Marco
Galli, Jacopo https://orcid.org/0000-0003-1599-4573
- License Information
-
More Information
Article History
Received: 15 November 2023
Accepted: 11 December 2023
First Online: 29 December 2023
Declarations
:
: E. De Corso: lecture fees and participations on expert board meeting of GSK, Novartis, Sanofi, AstraZeneca. C. Montuori, D. P. Porru, G. D’Agostino, D. Penazzi, G. De Maio, L.M. D’Auria, J. Galli, S. Baroni, M.E. Onori, F. Sarlo, M. Corbò, R.F. Mastrapasqua: none.
: The study was approved by the local ethics committee (number of protocols: ID 4429). This study was performed in line with the principles of the Declaration of Helsinki. Informed consent about privacy and utilisation of clinical data was obtained from all patients at the time of original data collection. Clinical data were anonymously analysed.
